<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04146844</url>
  </required_header>
  <id_info>
    <org_study_id>GoztepeTRH1</org_study_id>
    <nct_id>NCT04146844</nct_id>
  </id_info>
  <brief_title>Prevalence of Two Major Geriatric Syndromes: Sarcopenia and Frailty</brief_title>
  <official_title>Prevalence of Two Major Geriatric Syndromes in Community- Dwelling Older Adults: Sarcopenia and Frailty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goztepe Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Goztepe Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia and frailty are two major syndromes in older adults. They are shown to be
      associated with low levels of functioning and higher rates of morbidity and mortality. In
      this study, we aim to report the prevalence of sarcopenia and frailty by using simple
      assessment methods such as SARC-F and FRAIL, respectively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 28, 2019</start_date>
  <completion_date type="Actual">February 25, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SARC-F</measure>
    <time_frame>5 minutes</time_frame>
    <description>SARC-F is a rapid tool to assess sarcopenia in elderly. It is considered indicative sign of sarcopenia if the person scores 4 points or higher out of 10 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FRAIL</measure>
    <time_frame>5 minutes</time_frame>
    <description>The FRAIL scale (Fatigue, Resistance, Ambulation, Illnesses, &amp; Loss of Weight) is a simple questionnaire of frailty syndrome for older adults. If a patient scores 3-5 points over a total score of 5 points in the FRAIL, he is considered as frail.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study of Osteoporotic Fracture (SOF) Criteria for Frailty</measure>
    <time_frame>5 minutes</time_frame>
    <description>SOF is another index for measuring frailty. 2 or 3 points out of 3 points are considered as cut-off points for frailty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Charlson Comorbidity Index</measure>
    <time_frame>5-10 minutes</time_frame>
    <description>For comorbidity assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid Assessment of Physical Activity (RAPA)</measure>
    <time_frame>10 minutes</time_frame>
    <description>For the assessment of physical activity level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-Nutritional Assessment (MNA)</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessment of nutritional status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Katz Index of Independence in Activities of Daily Living</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessment of activities of daily living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lawton -Brody Instrumental Activities of Daily Living Scale</measure>
    <time_frame>10 minutes</time_frame>
    <description>Instrumental activities of daily living assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-Mental State Examination</measure>
    <time_frame>15 minutes</time_frame>
    <description>Mini-Mental State Examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Sample Analysis</measure>
    <time_frame>5 minutes</time_frame>
    <description>A blood sample analysis will be performed to investigate the relationship between blood parameters, sarcopenia and frailty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale- Short Form</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessment of depression</description>
  </secondary_outcome>
  <enrollment type="Actual">500</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Frailty</condition>
  <condition>Frailty Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Community-dwelling older adults
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being at the age of 65 or older

        Exclusion Criteria:

          -  &lt;24 points on Mini-Mental State Examination

          -  12 points or higher on Geriatric Depression Scale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Goztepe Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34722</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>October 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goztepe Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Filiz DemirdaÄŸ</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

